126 related articles for article (PubMed ID: 9271020)
1. Detection of minimal residual disease in an AML patient with trisomy 8 using interphase fish.
White DL; Hutchins CJ; Turczynowicz S; Suttle J; Haylock DN; Hughes TP; Juttner CA; To LB
Pathology; 1997 Aug; 29(3):289-93. PubMed ID: 9271020
[TBL] [Abstract][Full Text] [Related]
2. Detection and monitoring of trisomy 8 by fluorescence in situ hybridization in acute myeloid leukemia: a multicentric study.
Cuneo A; Bigoni R; Roberti MG; Bardi A; Rigolin GM; Piva N; Mancini M; Nanni M; Alimena G; Mecucci C; Matteucci C; La Starza R; Bernasconi P; Cavigliano P; Genini E; Zaccaria A; Testoni N; Carboni C; Castoldi G
Haematologica; 1998 Jan; 83(1):21-6. PubMed ID: 9542319
[TBL] [Abstract][Full Text] [Related]
3. Detection of minimal residual disease in peripheral blood stem cells from two acute myeloid leukemia patients with trisomy 8 predicts early relapse after autologous bone marrow transplantation.
Scaravaglio P; Guglielmelli T; Giugliano E; Marmont F; Audisio E; Gallo E; Saglio G; Rege-Cambrin G
Cancer Genet Cytogenet; 2002 Feb; 133(1):98-101. PubMed ID: 11890999
[TBL] [Abstract][Full Text] [Related]
4. Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow-up of patients in clinical remission.
Engel H; Goodacre A; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Andreeff M
Br J Haematol; 1997 Oct; 99(1):64-75. PubMed ID: 9359505
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of complete disease remission in acute myeloid leukemia: a prospective study based on cytomorphology, interphase fluorescence in situ hybridization, and immunophenotyping during follow-up in patients with acute myeloid leukemia.
Bacher U; Kern W; Schoch C; Schnittger S; Hiddemann W; Haferlach T
Cancer; 2006 Feb; 106(4):839-47. PubMed ID: 16419072
[TBL] [Abstract][Full Text] [Related]
6. Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology.
Bernell P; Jacobsson B; Nordgren A; Hast R
Leukemia; 1996 Apr; 10(4):662-8. PubMed ID: 8618444
[TBL] [Abstract][Full Text] [Related]
7. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
[TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease using fluorescence DNA in situ hybridization: a follow-up study in leukemia and lymphoma patients.
Nylund SJ; Ruutu T; Saarinen U; Larramendy ML; Knuutila S
Leukemia; 1994 Apr; 8(4):587-94. PubMed ID: 8152255
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of minimal residual disease in acute myelogenous leukemia and myelodysplastic syndromes in complete remission by molecular cytogenetics of progenitor cells.
Engel H; Drach J; Keyhani A; Jiang S; Van NT; Kimmel M; Sanchez-Williams G; Goodacre A; Andreeff M
Leukemia; 1999 Apr; 13(4):568-77. PubMed ID: 10214863
[TBL] [Abstract][Full Text] [Related]
10. [Detection of abnormal numbers of chromosome 8 with interphase fluorescence in situ hybridization in hematologic malignancies].
Wang HP; Li GX; Qiao ZH; Wang HW
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Aug; 21(4):395-7. PubMed ID: 15300644
[TBL] [Abstract][Full Text] [Related]
11. Clonal chromosomal abnormalities in the stem cell compartment of patients with acute myeloid leukemia in morphological complete remission.
Feuring-Buske M; Haase D; Buske C; Hiddemann W; Wörmann B
Leukemia; 1999 Mar; 13(3):386-92. PubMed ID: 10086729
[TBL] [Abstract][Full Text] [Related]
12. Minimal residual disease (MRD) in remission t(8;21) AML and in vivo differentiation detected by FISH and CD34+ cell sorting.
Varella-Garcia M; Hogan CJ; Odom LF; Murata-Collins JL; Ai H; Chen L; Richkind K; Paskulin G; Andreeff M; Brizard A; McGavran L; Gemmill RM; Berger R; Drabkin HA
Leukemia; 2001 Sep; 15(9):1408-14. PubMed ID: 11516101
[TBL] [Abstract][Full Text] [Related]
13. [Detection of trisomy 8 with interphase fluorescence in situ hybridization in myelodysplastic syndromes].
Li J; Pan J; Xue Y; Wu C; Xie X; Guo Y; Ruan C
Zhonghua Xue Ye Xue Za Zhi; 2000 Apr; 21(4):179-81. PubMed ID: 11876976
[TBL] [Abstract][Full Text] [Related]
14. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
[TBL] [Abstract][Full Text] [Related]
15. Interphase FISH and morphologic analysis of AML.
Pagliaro LC; Stanley WS
Cancer Genet Cytogenet; 1993 Jun; 67(2):95-100. PubMed ID: 8330277
[TBL] [Abstract][Full Text] [Related]
16. Isolated tetrasomy 8 in minimally differentiated acute myeloid leukemia (AML-M0).
Xue Y; Guo Y; Zhou Y; Xie X; Zheng L; Shen M
Leuk Lymphoma; 1999 May; 33(5-6):581-5. PubMed ID: 10342586
[TBL] [Abstract][Full Text] [Related]
17. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests.
Díez-Martín JL; Buño I; Llamas P; Gosálvez J; López-Fernández C; Polo N; Regidor C
Cancer Detect Prev; 2000; 24(2):169-72. PubMed ID: 10917138
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of detection of trisomy 8 with fluorescence in situ hybridization and conventional karyotype analysis in myelodysplastic syndrome].
Zhang ZB; Liu SH; Li J; Bo LJ; Cui HY; Liu XP; Nie YX; Qin S
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Apr; 10(2):115-8. PubMed ID: 12513811
[TBL] [Abstract][Full Text] [Related]
19. [Clonal analysis by fluorescence in situ hybridization in a patient with de nove acute myeloid leukemia with myelodysplasia].
Hyakuna N; Naritomi K; China K; Gushiken T; Tohma T; Ito E
Rinsho Ketsueki; 1997 Sep; 38(9):776-81. PubMed ID: 9364870
[TBL] [Abstract][Full Text] [Related]
20. Design and validation of DNA probe sets for a comprehensive interphase cytogenetic analysis of acute myeloid leukemia.
Fischer K; Scholl C; Sàlat J; Fröhling S; Schlenk R; Bentz M; Stilgenbauer S; Lichter P; Döhner H
Blood; 1996 Nov; 88(10):3962-71. PubMed ID: 8916963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
